BORIS Promotes Regulatory Interactions of Chromatin in Therapy-Resistant Most cancers Cells
Dixon, J. R. et al. Topological domains in mammalian genomes recognized by evaluation of chromatin interactions. Nature 485, 376-380 (2012).
Phillips-Cremins, J.E. et al. Subclasses of architectural proteins form the 3D group of genomes throughout lineage engagement. Cell 153, 1281-1295 (2013).
Hnisz, D. et al. Activation of proto-oncogenes by disruption of chromosomal neighborhoods. Science 351, 1454-1458 (2016).
Katainen, R. et al. CTCF / cohesin binding websites are incessantly mutated in most cancers. Nat. Broom. 47, 818-821 (2015).
Flavahan, W. A. et al. Insertional dysfunction and activation of the oncogene in mutant IDH gliomas. Nature 529, 110-114 (2016).
Loukinov, D.I. et al. BORIS, a brand new male germline-specific protein related to epigenetic reprogramming occasions, shares the identical 11-finger zinc area because the CTCF, the insulating protein concerned in studying marks printed in soma. Proc. Natl Acad. Sci. USA 99, 6806-6811 (2002).
Klenova, E.M., Morse, H.C. III, Ohlsson, R. and Lobanenkov, V.V. The brand new gene household BORIS + CTCF is uniquely concerned within the epigenetics of regular biology and most cancers. Semin. Most cancers Biol. 12, 399-414 (2002).
Martin-Kleiner, I. BORIS in human cancers – a evaluate. EUR. J. Most cancers 48, 929-935 (2012).
Garikapati, Ok. R. et al. The downregulation of BORIS / CTCFL successfully regulates most cancers pressure and metastasis within the MYCN-amplified neuroblastoma cell line by modulating the Wnt / β-catenin signaling pathway. Biochem. Biophys. Res. Frequent. 484, 93-99 (2017).
Cheung, N. Ok. & Dyer, M. A. Neuroblastoma: developmental biology, most cancers genomics and immunotherapy. Nat. Rev. Most cancers 13, 397-411 (2013).
Monk, M., Hitchins, M. and Hawes, S. Differential expression of the embryo / most cancers gene ECSA (DPPA2), the BORIS most cancers / testis gene and the pluripotency structural gene OCT4 in human preimplantation growth. Mol. Hum. Reprod. 14, 347-355 (2008).
Brodeur, G.M., Seeger, R.C., Schwab, M.Varmus, H.E. & Bishop, J.M. The amplification of N-myc in untreated human neuroblastomas is correlated with the superior stage of the illness. Science 224, 1121-1124 (1984).
George, R.E. et al. Activating mutations in ALK present a therapeutic goal in neuroblastoma. Nature 455, 975-978 (2008).
Galkin, A.V. et al. Identification of NVP-TAE684, a potent, selective and efficient inhibitor of NPM-ALK. Proc. Natl Acad. Sci. USA 104, 270-275 (2007).
Chipumuro, E. et al. The inhibition of CDK7 suppresses oncogenic transcription associated to the super-amplifier in cancers induced by MYCN. Cell 159, 1126-1139 (2014).
Durbin, A. D. et al. Selective gene dependencies in MYCN-amplified neuroblastoma embody fundamental transcriptional regulatory circuits. Nat. Broom. 50, 1240-1246 (2018).
van der Maaten, L. & Hinton, G. Viewing information with the assistance of t-SNE. J. Mach. Study. Res. 9, 2579-2605 (2008).
Zeid, R. et al. The invasion of the amplifier shapes the amplification of MYCN-dependent transcription in neuroblastoma. Nat. Broom. 50, 515-523 (2018).
Muhar, M. et al. SLAM-seq defines the direct gene regulation capabilities of the BRD4-MYC axis. Science 360, 800-805 (2018).
Wegner, M. & Stolt, C., C. From stem cells to neurons and glial cells: a soxistic view of neural growth. Neurosci Developments. 28, 583-588 (2005).
Gao, Y. et al. Overcome resistance to the THZ collection of covalent inhibitors of transcriptional CDK. Cell Chem. Biol. 25, 135-142 (2018).
Pugacheva, E.M. et al. Comparative analyzes of the CTCF and BORIS occupations reveal two distinct courses of genomic CTCF binding areas. Genome Biol. 16,161 (2015).
Bergmaier, P. et al. The selection of CTCFL binding websites relative to CTCF depends upon chromatin and sequence preferences. Nucleic Acids Res. 46, 7097-7107 (2018).
Mumbach, M. R. et al. HiChIP: an environment friendly and delicate evaluation of the structure of the genome directed by proteins. Nat. Strategies 13, 919-922 (2016).
Dowen, J.M. et al. The management of cell identification genes takes place in remoted quarters of mammalian chromosomes. Cell 159, 374-387 (2014).
Sanborn, A. L. et al. Chromatin extrusion explains the primary options of loop formation and domains in wild-type and modified genomes. Proc. Natl Acad. Sci. USA 112, E6456 to E6465 (2015).
Whyte, W. A. et al. The most important transcription elements and the mediator set up super-amplifiers on the stage of key cell identification genes. Cell 153, 307-319 (2013).
Hnisz, D. et al. Tremendous activators within the management of cell identification and illness. Cell 155, 934-9477 (2013).
Kumar, J. P. The household of transcription elements sine oculis homeobox (SIX) as regulators of growth and illness. Cell. Mol. Life Sci. 66, 565-583 (2009).
Dennis, D.J., Han, S. and Schuurmans, C. BHLH transcription elements in neural growth, illness and reprogramming. Mind Res. 1705, 48-65 (2019).
Batra, S., Reynolds, C.P. and Maurer, B. J. The cytotoxicity of fenretinide for Ewing's sarcomas and primitive neuroectodermal tumor cell strains is decreased by hypoxia and synergistically enhanced by ceramide modulators. Most cancers Res. 64, 5415-5244 (2004).
Whang-Peng, J. et al. Cytogenetic characterization of small tumors with chosen spherical cells of childhood. Most cancers Genet. Cytogenet. 21, 185-208 (1986).
Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067-1073 (2010).
Marsilje, T.H. et al. Synthesis, structure-activity relationships and in vivo efficacy of the brand new potent and selective inhibitor of anaplastic lymphoma kinase (ALK), 5-chloro-N2- (2-isopropoxy-5-methyl-Four- (piperidin-Four-yl) phenyl) ) -N4- (2- (isopropylsulfonyl) phenyl) pyrimidine-2,Four-diamine (LDK378) in Part 1 and Part 2 medical trials. J. Med. Chem. 56, 5675-5690 (2013).
Johnson, T. W. et al. Discovery of (10R) -7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-Eight,Four- (metheno) pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-Three-carbonitrile (PF-06463922), macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros 1 (ROS1) oncogene with preclinical publicity to the mind and broad-spectrum energy towards resistant mutations l & # 39; KLA. J. Med. Chem. 57, 4720-4744 (2014).
Gosmini, R. et al. The invention of I-BET726 (GSK1324726A), a potent regulatory regulator of tetrahydroquinoline ApoA1 and a selective inhibitor of BET bromodomain. J. Med. Chem. 57, 8111-8131 (2014).
Lovén, J. et al. Revisit the general evaluation of gene expression. Cell 151, 476-482 (2012).
Debruyne, D.N. et al. The resistance of ALK inhibitors in ALK-induced neuroblastomas (F1174L) is related to activation of AXL and induction of TEM. Oncogene 35, 3681-3691 (2016).
Sancak, Y. et al. RTP GTPases bind Raptor and mediate the signaling of amino acids to mTORC1. Science 320, 1496-1501 (2008).
Meerbrey, Ok.L. et al. The pINDUCER lentiviral toolbox for RNA inducible interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665-3670 (2011).
Tomayko, M.M. & Reynolds, C.P. Willpower of subcutaneous tumor dimension in athymic (nude) mice. Most cancers Chemother. Pharmacol. 24, 148-154 (1989).
Zheng, G. X. et al. Massively parallel digital transcription profile of particular person cells. Nat. Frequent. Eight, 14049 (2017).
Gautier, L., Cope, L., Bolstad, B.M. and Irizarry, R.A. Affy – Evaluation of Affymetrix GeneChip information on the probe. Bioinformatics 20, 307-315 (2004).
Smyth, G.Ok., Yang, Y.H. and Velocity, T. Statistical issues within the evaluation of cDNA chip information. Mol. Biol. 224, 111-136 (2003).
Bolger, A.M., Lohse, M. and Usadel, B. Trimmomatic: a versatile trimmer for Illumina sequence information. Bioinformatics 30, 2114-2120 (2014).
Servant, N. et al. HiC-Professional: an optimized and versatile pipeline for Hello-C information processing. Genome Biol. 16, 259 (2015).
Lareau, C. A. & Aryee, M. J. Diffloop: a pc framework for the identification and evaluation of differential DNA loops from sequencing information. Bioinformatics 34, 672-674 (2018).
Ji, X. et al. Regulatory panorama of 3D chromosomes of human pluripotent cells. Cell Stem Cell 18, 262-275 (2016).
Heinz, S. et al. Easy mixtures of lineage-determining transcription elements optimize the cis-regulatory components essential for the identities of macrophages and B cells. Mol. Cell 38, 576-589 (2010).
Consortium SEQC / MAQC-III. A complete evaluation of the accuracy, reproducibility and content material of the seq-RNA info by the Sequencing High quality Management Consortium. Nat. Biotechnol. 32, 903-914 (2014).
Savola, S. et al. The sturdy expression of complement element 5 (C5) on the website of the tumor is related to superior survival within the Ewing's sarcoma household of tumor sufferers. ISRN Oncol. 2011, 168712 (2011).
Huang, S. et al. Analytical efficiency of a 15-gene prognostic assay for early stage non-small cell lung most cancers utilizing RNA stabilized tissue. JMD 17, 438-445 (2015).
Li, M. et al. The built-in evaluation of DNA methylation and gene expression reveals particular signaling pathways related to platinum resistance in ovarian most cancers. BMC Med. Genomics 2, 34 (2009).
Liu, L. et al. New mechanism of resistance to lapatinib in HER2-positive breast tumor cells: activation of AXL. Most cancers Res. 69, 6871-6878 (2009).
Beier, D. et al. Cancerous stem cells derived from glioblastoma CD133 + and CD133- present totally different development traits and molecular profiles. Most cancers Res. 67, 4010-4015 (2007).